Some of allergy's top leaders converged on Washington, DC to advocate for issues important to you and your patients.
This joint statement by iCAALL calls attention to the impact and relevance of allergy specialists.
The production of venom extracts should not be interrupted due to ALK’s departure from the U.S. market.
ALK will no longer supply venom extracts in the U.S.
The College encourages legislators to support and fund CHIP.
Compare 2018 RVUs and payment to 2017 for key allergy CPT codes.
The Advocacy Council sent a letter to CMS on July 12, 2017 in support of reducing regulatory burdens on practices.
The Advocacy Council submitted comments to CMS on Sept. 11, 2017 about issues important to allergists on the proposed 2018 Physician Fee Schedule.